Trials / Completed
CompletedNCT04379154
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by (SARS-CoV-2): Predictive Interest in Short-term Evolution
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study of volatile organic compounds (VOCs) detected in exhaled air is an innovative research area for respiratory diseases. This analysis can be done by the technique of electronic nose, simpler and faster, which provides an idea of the general profile of the VOCs without identifying them. The VOCs in exhaled air in patients hospitalized for COVID-19 infection are analysed in this study, using electronic noses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Volatile Organic Compounds analysis | Volatile Organic Compounds analysis in exhaled air by electronic noses |
Timeline
- Start date
- 2020-04-14
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-05-07
- Last updated
- 2022-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04379154. Inclusion in this directory is not an endorsement.